Migraine: Aspirin and an antiemetic is a reasonable option

Apr 14, 2010

A single dose of 900-1000 mg aspirin can substantially reduce migraine headache pain within two hours, for more than half of people who take it. It also reduces any associated nausea, vomiting, and sensitivity to light or sound (photophobia or phonophobia). Formulations of aspirin 900 mg together with 10 mg of the antiemetic metoclopramide are better than placebo at reducing symptoms of nausea and vomiting. These were the findings of a Cochrane Systematic Review using data from 13 studies with 4,222 participants.

Migraine affects about 18% women and 6% of men in western populations, mostly affecting people 30 to 50 years old. The common symptom, whatever type of migraine someone has, is a severe headache, typically once or twice a month, lasting between four and 72 hours.

The headache is often pounding, on one side of the head, frequently with nausea, and sometimes with vomiting. Given the numbers of people affected, and the extent of the pain caused, migraine has considerable social and economic impact.

What sufferers want is for the pain to go away completely and quickly, and not return - though for many the headache does return within 24 hours of the first attack. Despite being common and debilitating, many sufferers choose to use only medicines available without prescription from pharmacies (over the counter, OTC medicines), or use OTC medicines to supplement prescription medicines, but good reviews of the evidence have been lacking. In the review published this week, Cochrane Researchers compared the differences in response rates for people taking alone or aspirin plus an antiemetic with those of people taking placebo or another active agent.

Researchers found that severe or moderate pain can be reduced from moderate or severe to no pain in 25% of people (one in four) within two hours by taking a single dose of 900-1000 mg aspirin alone compared to placebo, with pain reduced to no worse than mild pain in 52% (one in two). While aspirin alone reduced some of the associated symptoms of nausea, vomiting, photophobia and phonophobia, aspirin plus was particularly good a reducing nausea and vomiting, though it produced no greater frequency of pain relief.

Researchers also found that a combination of aspirin and metoclopramide had a similar effect to 50 mg of the headache treatment sumatriptan (a serotonin agonist), but that a 100 mg dose of sumatriptan was slightly better at delivering a pain free response within two hours of taking the medication.

In terms of adverse effects, short-term use of the different drugs produced mostly mild and transient adverse effects. These occurred more commonly when taking aspirin than when taking a , and more commonly when taking 100 mg sumatriptan than when taking aspirin plus metoclopramide.

"Aspirin plus metoclopramide will be a reasonable therapy for acute attacks, but for many it will be insufficiently effective," said the study leader Andrew Moore, who works in Pain Relief and the Department of Anaesthetics at the John Radcliffe Hospital, Oxford, UK.

"We are presently working on reviews of other OTC medicines for migraines, to provide consumers with the best available evidence on treatments that don't need a prescription."

Explore further: Malaysia reports first Asian death from MERS virus

add to favorites email to friend print save as pdf

Related Stories

Combination drug taken early relieves migraine symptoms

Jul 07, 2008

A combination drug taken within an hour after the start of a migraine is effective in relieving symptoms, according to research published in the July 8, 2008, issue of Neurology, the medical journal of the American Academ ...

Migraine increases risk of severe skin sensitivity and pain

Apr 21, 2008

People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing one’s head, combing one’s hair and wearing necklaces or earrings, compared to ...

New treatment effective for most severe kind of headache

Aug 27, 2007

A nasal spray is safe and effective at rapidly treating cluster headaches, which are considered to be the most painful kind of headache with few treatment options, according to a study published in the August 28, 2007, issue ...

Recommended for you

Ebola virus in Africa outbreak is a new strain

27 minutes ago

The Ebola virus that has killed scores of people in Guinea this year is a new strain—evidence that the disease did not spread there from outbreaks in some other African nations, scientists report.

Researchers see hospitalization records as additional tool

56 minutes ago

Comparing hospitalization records with data reported to local boards of health presents a more accurate way to monitor how well communities track disease outbreaks, according to a paper published April 16 in the journal PLOS ON ...

Malaysia reports first Asian death from MERS virus

7 hours ago

A Malaysian man who went on a pilgrimage to Saudi Arabia has become the first death in Asia from Middle East respiratory syndrome, while the Philippines has isolated a health worker who tested positive for the deadly coronavirus.

User comments : 0

More news stories

Researchers see hospitalization records as additional tool

Comparing hospitalization records with data reported to local boards of health presents a more accurate way to monitor how well communities track disease outbreaks, according to a paper published April 16 in the journal PLOS ON ...

Ebola virus in Africa outbreak is a new strain

Scientists say that the Ebola (ee-BOH'-lah) virus that has killed scores of people this year in Guinea (GIH'-nee) is a new strain. That means it did not spread there from outbreaks in some other African nations.